Browsing by Author Burmeister, Bryan H.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2015Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trialHong, Angela; Scolyer, Richard; Shannon, Kerwin; Thompson, John; Ainslie, Jill; Babington, Scott; Burmeister, Bryan H.; Carruthers, Scott; Coventry, Brendon; Di Iulio, Juliana; Duprat, Joao; Fisher, Richard; Henderson, M; Hoekstra, Harald J.; Smithers, B. Mark; Central Clinical School: Medicine; Central Clinical School: Pathology; Medicine; Central Clinical School: SurgeryAdjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial, Lancet Oncology, vol.16, 9, 2015,pp 1049-1060
2012Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialHong, Angela; Scolyer, Richard; Shannon, Kerwin; Thompson, John; Ainslie, Jill; Babington, Scott; Burmeister, Bryan H.; Carruthers, Scott; Coventry, Brendon J; Dilulio, J.; Duprat, Joao; Fisher, Richard; Henderson, Michael A.; Hoekstra, Harald J.; Smithers, Bernard Mark; Central Clinical School: Medicine; Central Clinical School: Pathology; Medicine; Central Clinical School: SurgeryAdjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial, Lancet Oncology, vol.13, 6, 2012,pp 589-597
2015Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma ModuleBoyle, Frances; King, Madeleine; Saw, Robyn; Thompson, John; Winstanley, Julie; Bergenmar, Mia; Bottomley, Andrew; Burmeister, Bryan H.; Campana, L; Garioch, Jennifer; Nikolic, Dejan; van de Poll-Franse, Lonneke; White, Edward; Young, Teresa; Northern Clinical School: Medicine; Psychology; Central Clinical School: Surgery; Central Clinical School: Surgery; Northern Clinical School: MedicineCross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma Module, Melanoma Research, vol.25, N/A, 2015,pp 47-58
2015First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data qualityDhillon, Haryana; Fogarty, Gerald; Hong, Angela; Hruby, George; Scolyer, Richard; Thompson, John; Vardy, Janette; Burmeister, Bryan H.; Dolven-Jacobson, Kari; Drummond, Kate; Haydu, Lauren; Mandel, Catherine; Nowak, Anna; Reisse, Claudius; Shivalingam, Brindha; Steel, Victoria; Psychology; Northern Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: Surgery; Concord Clinical School: MedicineFirst interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality, BMC Research Notes, vol.8, N/A, 2015,pp 1-6
2016The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04)Solomon, Michael; Ackland, Stephen; Burmeister, Bryan H.; Fisher, Richard; Goldstein, David; Leong, Trevor; Mackay, John; McClure, Bev; McKendrick, Joseph; McLachlan, Sue Anne; Ngan, S. Y.; Zalcberg, John; Central Clinical School: SurgeryThe impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04), European Journal of Cancer, vol.55, N/A, 2016,pp 15-26
2012Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04Solomon, Michael; Ackland, Stephen; Burmeister, Bryan H.; Fisher, Richard; Goldstein, D; Hartopeanu, Chris; Joseph, David; Leong, T.; Mackay, John; McClure, Bev; McKendrick, J; McLachlan, Sue Anne; Ngan, S. Y.; Schache, David; Zalcberg, John; Central Clinical School: SurgeryRandomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04, Journal of Clinical Oncology, vol.30, 31, 2012,pp 3827-3833
2005Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.Ackland, Stephen; Fitzgerald, Lara; Gebski, Val; Joseph, D; Simes, Robert John; Walpole, Euan; Burmeister, Bryan H.; Devitt, Peter G.; et, al; Gotley, David C.; Millar, Jeremy L.; North, John; Smithers, Bernard Mark; Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Surgery; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreSurgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial., Lancet Oncology, vol.6,(9),2005,pp 659-668
2011Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysisGebski, Val; Simes, Robert John; Sjoquist, Katrin; Barbour, Andrew; Burmeister, Bryan H.; Smithers, Bernard Mark; Zalcberg, John; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreSurvival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis, Lancet Oncology, vol.12, 7, 2011,pp 681-692
2007Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysisFoo, Kerwyn; Gebski, Val; Simes, Robert John; Burmeister, Bryan H.; Smithers, Bernard Mark; Zalcberg, John; Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreSurvival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis, Lancet Oncology, vol.8,(3),2007,pp 226-234